Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2150 (LINC02150) is a human long non-coding RNA gene, located on chromosome 5, annotated as non-protein coding. LINC02150 is not a classical druggable therapeutic target such as a receptor, enzyme, or ion channel, but has emerged in bioinformatics screens as a potential diagnostic biomarker due to its differential expression in cancers, particularly in lung cancer datasets. Like other lncRNAs, it likely functions in gene expression regulation at the chromatin or transcript level, but its precise molecular mechanisms remain uncharacterized. There are currently no known small molecule or biological drugs reported to target LINC02150 directly, nor specific mechanisms of action or safety data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2150 (LINC02150).